GGrantIndex
← Leaderboards

Richard Whitley

University Of Alabama At Birmingham

$35,051,642
Attributed
$35,051,642
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $11.4M · FY201015
$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$27,933,073 · 6
CDC$7,118,569 · 2

By mechanism

N01$27,933,073 · 6
H23$6,291,204 · 1
U50$827,365 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Virus Diseases

Research focus

Virus DiseasesProgramsTherapy DevelopmentClinical ResearchPatient PopulationChildhoodClinical TrialsPharmacodynamicsPhase Ii Clinical TrialsSimplexvirusDrug KineticsCytomegalovirusCongenital CytomegalovirusDrug ResistanceCongenital Herpes SimplexCentral Nervous System InfectionsAntimicrobial ResistanceTransplant RecipientsBk VirusTherapeutic EvaluationPregnant WomenMedicalAntiviral TherapyContracts

Grant awards (27)

NEVADA IMMUNIZATION AND VACCINES FOR CHILDREN$3,048,726
H23 · FY2015 · IP · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$819,823
N01 · FY2015 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$809,771
N01 · FY2015 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$725,538
N01 · FY2015 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$681,306
N01 · FY2015 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$631,063
N01 · FY2015 · AI · contact PI
NEVADA IMMUNIZATION AND VACCINES FOR CHILDREN$215,379
H23 · FY2015 · IP · contact PI
NEVADA IMMUNIZATION AND VACCINES FOR CHILDREN$3,027,099
H23 · FY2014 · IP · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$1,246,266
N01 · FY2014 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$1,028,158
N01 · FY2014 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$817,792
N01 · FY2014 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$746,497
N01 · FY2014 · AI · contact PI
OE12-1202 BioSense 2.0$272,974
U50 · FY2014 · CD · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$1,436,332
N01 · FY2013 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$1,025,857
N01 · FY2013 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$744,300
N01 · FY2013 · AI · contact PI
OE12-1202 BioSense 2.0$272,974
U50 · FY2013 · CD · contact PI
OE12-1202 BioSense 2.0$281,417
U50 · FY2012 · CD · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$3,385,690
N01 · FY2011 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$2,065,894
N01 · FY2011 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$1,779,753
N01 · FY2011 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$1,094,235
N01 · FY2011 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$1,094,235
N01 · FY2011 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$983,639
N01 · FY2011 · AI · contact PI
Targeted Clinical Research Program to Address Selected Viral Infections$983,638
N01 · FY2011 · AI · contact PI
Clinical Trials for Antiviral Therapies$4,666,629
N01 · FY2010 · AI · contact PI
Clinical Trials for Antiviral Therapies$1,166,657
N01 · FY2010 · AI · contact PI